ÂÜÀòÂÒÂ×

Neil Berkley is a prominent executive in the biopharmaceutical industry, currently serving as the Chief Business Officer at Alector since April 2024 and a Board Member at Abalone Bio. Prior roles include Chief Corporate Development Officer at Juvena Therapeutics, where responsibilities encompassed partnering, IP/legal operations, corporate strategy, and fundraising, and Chief Business Officer at AbCellera. Berkley has held key positions in business development and corporate strategy at notable companies such as Halozyme Therapeutics and ACADIA Pharmaceuticals. With an educational background in Molecular Biology (BS, MS) from San Diego State University and UC San Diego, alongside an MBA focused on Entrepreneurship from San Diego State University, Berkley possesses extensive expertise in the field.